Localization of α-adrenoceptors: JR Vane Medal Lecture

British Journal of Pharmacology

Volumn 172, Issue 5, 2015, Pages 1179-1194

  McGrath, John C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; NORADRENALIN; ADRENERGIC RECEPTOR; LIGAND;

BLOOD VESSEL WALL; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENDOCYTOSIS; ENDOTHELIUM; HUMAN; INTERNALIZATION; LIGAND BINDING; NONHUMAN; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; UPREGULATION; VALIDATION PROCESS; VASCULAR SMOOTH MUSCLE; WILD TYPE; ANIMAL; ARTERY; CHEMISTRY; CYTOLOGY; METABOLISM;

ANIMALS; ARTERIES; HUMANS; LIGANDS; RECEPTORS, ADRENERGIC;

EID: 84922823969     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13008     Document Type: Review

References (77)

1. Ahlquist RP, (1948). A study of the adrenotropic receptors. Am J Physiol 153: 586-600.
2. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol 170: 1449-1458.
3. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
4. 1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur J Pharmacol 543: 83-91.
5. Angus JA, Cocks TM, Satoh K, (1986). The alpha adrenoceptors on endothelial cells. Fed Proc 45: 2355-2359. PubMed [citation]. PMID: 3015689.
6. 2-adrenoceptor agonist. Br J Pharmacol 139: 232-242.
7. 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol 99: 803-809.
8. Bulloch JM, Daly CJ, (2014). Autonomic nerves and perivascular fat: interactive mechanisms. Pharmacol Ther 143: 61-73.
9. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, et al. (1994). International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121-136.
10. Carlsson A, Falck B, Hillarp NA, Thieme G, Torp A, (1961). A new histochemical method for visualization of tissue catechol amines. Med Exp Int J Exp Med 4: 123-125.
11. 1-adrenoceptor subtypes. Mol Pharmacol 61: 1008-1016.
12. Dale H, (1935). Pharmacology and nerve-endings (Walter Ernest Dixon Memorial Lecture): (Section of Therapeutics and Pharmacology). Proc R Soc Med 28: 319-332.
13. Dale H, (1943). Modes of drug action. General introductory address. Trans Faraday Soc 39: 319b-322.
14. Daly CJ, McGrath I, (2003). Fluorescent ligands, antibodies, and proteins for the study of receptors. Phamacol Ther 100: 101-118.
15. Daly CJ, McGrath JC, (2011). Previously unsuspected widespread cellular and tissue distribution of beta-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci 32: 219-226.
16. Daly CJ, Gordon JF, McGrath JC, (1992). The use of fluorescent nuclear dyes for the study of blood vessel structure and function: novel applications of existing techniques. J Vasc Res 29: 41-48.
17. 1-adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. J Pharmacol Exp Ther 286: 984-990.
18. 1B-adrenoceptors in mouse. Physiol Genomics 9: 85-91.
19. Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC, (2010). Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. Br J Pharmacol 159: 787-796.
20. Daly CJ, Parmryd I, McGrath JC, (2012). Visualization and analysis of vascular receptors using confocal laser scanning microscopy and fluorescent ligands. Methods Mol Biol 897: 95-107.
21. 1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution. Br J Pharmacol 142: 1031-1037.
22. 1-adrenoceptor subtypes in mouse carotid arteries using knockout mice. Br J Pharmacol 144: 558-565.
23. 2-adrenoceptors in rabbit isolated distal saphenous artery-a permissive role for angiotensin II? Br J Pharmacol 96: 259-261.
24. 1D-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed. J Pharmacol Exp Ther 296: 869-875.
25. 1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries. Pharmacol Res Perspect 1: e00001.
26. Fleckenstein A, (1952). A quantitative study of antagonists of adrenaline on the vessels of the rabbit's ear. Br J Pharmacol Chemother 7: 553-562.
27. Furchgott RF, (1959). The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol Rev 11: 429-441, discussion 441-422.
28. Gillespie JS, McGrath JC, (1974). The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat anococcygeus muscle and vas deferens. Br J Pharmacol 52: 585-590.
29. 1-adrenergic receptor subtypes: non-identical triplets with different dancing partners? Life Sci 74: 411-418.
30. Hansen MA, Dutton JL, Balcar VJ, Barden JA, Bennett MR, (1999). P2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 75: 147-155.
31. 1-adrenoceptors: consensus update. Pharmacol Rev 47: 267-270.
32. 1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52: 764-770.
33. 1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 290: 452-463.
34. Ing HR, (1943). Chemical constitution and pharmacological action. Trans Faraday Soc 39: 372-380.
35. Langley JN, (1905). On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol 33: 374-413.
36. Langley JN, (1907). On the contraction of muscle, chiefly in relation to the presence of 'receptive' substances: part I. J Physiol 36: 347-384.
37. Luo D, Barker JR, McGrath JC, Daly CJ, (1998). Iterative multilevel thresholding and splitting for 3D segmentation of live cell nuclei using laser scanning confocal microscopy. J Comput Assist Microsc 10: 151-162.
38. 1-adrenoceptors in native smooth muscle cells. Online Proceedings of the 5th Internet World Congress on Biomedical Sciences '98 at McMaster University, Canada. download Available at: http://www.mcmaster.ca/inabis98/cvdisease/mackenzie0899/index.html (accessed 21/12/2014).
39. 1-adrenoceptors in human primary smooth muscle cells derived from the prostate of patients with benign prostatic hypertrophy. Eur Urol 36 (Suppl. 1): 115.
40. 1-adrenoceptor ligand-binding sites. J Pharmacol Exp Ther 294: 434-443.
41. 2A-adrenergic receptor by homologous recombination reveals the role of this receptor subtype in multiple physiological processes. Adv Pharmacol 42: 493-496. No abstract available, PubMed [citation]. PMID: 9327947.
42. 1D-Adrenoceptors by agonists and inverse agonists. Mol Pharmacol 57: 659-666.
43. McDougal MD, West GB, (1953). The action of drugs on isolated mammalian bronchial muscle. Br J Pharmacol Chemother 8: 26-29.
44. McGrath JC, Arribas SM, Daly CJ, Gordon JF, (1995). Confocal microscopy for structure and real-time pharmacology in blood vessels. J Hum Hypertens 9: 645-647.
45. McGrath J, Wilson V, (1988). Alpha-adrenoceptor subclassification by classical and response-related methods: same question, different answers. Trends Pharmacol Sci 9: 162-165.
46. McGrath JC, (1982). Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem Pharmacol 31: 467-484.
47. McGrath JC, Arribas S, Daly CJ, (1996a). Fluorescent ligands for the study of receptors. Trends Pharmacol Sci 17: 393-399.
48. McGrath JC, Arribas S, Daly CJ, (1996b). Fluorescent ligands for the study of receptors. Trends Pharmacol Sci 17: 393-399. PubMed [citation], Erratum in: Trends Pharmacol Sci 1997 May;18:181, Erratum was still incorrect, see figure 5. PMID: 8990953.
49. 1-adrenoceptors in native smooth muscle cells. J Auton Pharmacol 19: 303-310.
50. 1-adrenoceptors in human prostate. Eur Urol 36 (Suppl. 1): 80-88.
51. McGrath JC, Deighan C, Briones AM, Shafaroudi MM, McBride M, Adler J, et al. (2005). New aspects of vascular remodelling: the involvement of all vascular cell types. Exp Physiol 90: 469-475.
52. 1A-adrenoceptor and elucidates its relationship to the other subtypes. Br J Pharmacol 158: 209-224.
53. 1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes. Br J Pharmacol 158: 1663-1675.
54. 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol 118: 123-129.
55. Miquel MR, Segura V, Ali Z, D'Ocon MP, McGrath JC, Daly CJ, (2005). 3-d image analysis of fluorescent drug binding. Mol Imaging 4: 40-52.
56. 1A-adrenergic receptors is continuous and primarily agonist-independent. Mol Pharmacol 66: 843-854.
57. 1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. J Comp Neurol 478: 1-10.
58. 1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J Comp Neurol 497: 209-222.
59. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1106.
60. 2+, display subtype-characteristic agonism and antagonism, and exhibit an antagonist-reversible inverse concentration-response phase. J Pharmacol Exp Ther 293: 887-895.
61. 1A-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments. Mol Pharmacol 67: 992-1004.
62. Perez-Aso M, Segura V, Montõ F, Barettino D, Noguera MA, Milligan G, et al. (2013). The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation. Biochim Biophys Acta 1833: 2322-2333.
63. 1B-adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283: 854-868.
64. Saper CB, (2007). In living color. J Comp Neurol 502: 173-174.
65. 1B-adrenoceptors are related to different endosomal targeting. PLoS ONE 8: e64996. doi: 10.1371/journal.pone.0064996; Print 2013.
66. 2A-adrenoceptors located on the endothelium. J Pharmacol Exp Ther 314: 804-810.
67. Shang C, Daly CJ, McGrath JC, Barker JR, (2000a). Neural network based classification of cell images via estimation of fractal dimensions. In:, Malmgren H, Borga M, Niklasson L, (eds). Perspectives in Neural Computing. Springer Press: London, pp. 111-116. Proceedings of the International Conference on Artificial Neural Networks in Medicine and Biology, Goteborg, Sweden.
68. Shang C, Daly CJ, McGrath JC, Barker JR, (2000b). Analysis and classification of tissue section images using directional fractal dimension features. Proceedings of the IEEE International Conference on Image Processing. Vancouver, Canada. 1, 164-167.
69. Shang C, McGrath JC, Daly CJ, Barker JR, (2000c). Modelling and classification of vascular smooth muscle cell images. Electronics Letters-IEEE 36: 1532-1533.
70. Somoza B, Gonzalez MC, Gonzalez JM, Abderrahim F, Arribas SM, Fernandez-Alfonso MS, (2005). Modulatory role of the adventitia on noradrenaline and angiotensin II responses role of endothelium and AT2 receptors. Cardiovasc Res 65: 478-486.
71. Stafford A, (1963). Potentiation of some catechol amines by phenoxybenzamine, guanethidine and cocaine. Br J Pharmacol Chemother 21: 361-367.
72. Stanasila L, Abuin L, Dey J, Cotecchia S, (2008). Different Internalization Properties of the α1a- and α1b-Adrenergic Receptor Subtypes: The Potential Role of Receptor Interaction with β-Arrestins and AP50. Mol Pharmacol 74: 562-573.
73. Summers RJ, Molenaar P, (1995). Autoradiography of beta 1- and beta 2-adrenoceptors. Methods Mol Biol 41: 25-39.
74. Tickner A, (1951). Inhibition of amine oxidase by antihistamine compounds and related drugs. Br J Pharmacol Chemother 6: 606-610.
75. Vanhoutte PM, Humphrey PP, Spedding M, (1996). X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev 48: 1-2.
76. Wilson VG, Brown CM, McGrath JC, (1991). Are there more than two types of alpha-adrenoceptors involved in physiological responses? Exp Physiol 76: 317-346.
77. 1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedebergs Arch Pharmacol. 119: 269-277.